EXACTSIGN Trademark

Trademark Overview


On Wednesday, January 17, 2024, a trademark application was filed for EXACTSIGN with the United States Patent and Trademark Office. The USPTO has given the EXACTSIGN trademark a serial number of 98362194. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 2, 2024. This trademark is owned by Hangzhou Biotest Biotech Co., Ltd.. The EXACTSIGN trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of HIV, Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A (HAV), Helicobacter pylori (H. pylori), Dengue, and Syphilis; Chemical preparations for pharmaceutical or medical purposes, namely, for pregnancy testing preparations, tumor testing preparations, infectious disease testing preparations, cardiovascular disease testing preparations, drug testing preparations and immune disease testing preparations; Chemical preparations for the diagnosis of pregnancy; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Pharmaceutical preparations for diagnosing infectious diseases, early stage pregnancy and tumors
exactsign

General Information


Serial Number98362194
Word MarkEXACTSIGN
Filing DateWednesday, January 17, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 8, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording "EXACTSIGN", wherein the dot of the letter "I" is replaced with a pair of flying ribbons.
Goods and ServicesBiological preparations for the treatment of HIV, Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A (HAV), Helicobacter pylori (H. pylori), Dengue, and Syphilis; Chemical preparations for pharmaceutical or medical purposes, namely, for pregnancy testing preparations, tumor testing preparations, infectious disease testing preparations, cardiovascular disease testing preparations, drug testing preparations and immune disease testing preparations; Chemical preparations for the diagnosis of pregnancy; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Pharmaceutical preparations for diagnosing infectious diseases, early stage pregnancy and tumors
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 17, 2024
Primary Code005
First Use Anywhere DateMonday, July 27, 2020
First Use In Commerce DateTuesday, December 1, 2020

Trademark Owner History


Party NameHangzhou Biotest Biotech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZhejiang Province 311100
CN

Trademark Events


Event DateEvent Description
Wednesday, January 17, 2024NEW APPLICATION ENTERED
Monday, March 25, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2024ASSIGNED TO EXAMINER
Tuesday, July 16, 2024NON-FINAL ACTION E-MAILED
Friday, August 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER